nifedipine has been researched along with trandolapril in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pauly, NC; Steiner, G | 1 |
| Capaldo, B; Carretta, R; Fabris, F; Ferrara, LA; Galletti, F; Glorioso, N; Mancini, M; Semplicini, A; Strazzullo, P | 1 |
| Cominacini, L; Ferrannini, E; Franzoni, F; Fratta-Pasini, A; Galetta, F; Garbin, U; Natali, A; Pucciarelli, A; Quiñones-Galvan, A | 1 |
| Ciociaro, D; Ferrannini, E; Franzoni, F; Masoni, A; Natali, A; Pucciarelli, A; Quiñones-Galvan, A | 1 |
| Karpov, IuA | 1 |
2 review(s) available for nifedipine and trandolapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
4 trial(s) available for nifedipine and trandolapril
| Article | Year |
|---|---|
Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Delayed-Action Preparations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Nifedipine; Single-Blind Method | 1994 |
Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Calcium; Calcium Channel Blockers; Female; Follow-Up Studies; Forearm; Glucose; Glucose Tolerance Test; Humans; Hypertension; Indoles; Insulin Resistance; Italy; Male; Middle Aged; Muscle, Skeletal; Nifedipine; Obesity; Peptidyl-Dipeptidase A; Treatment Outcome | 1999 |
Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Malondialdehyde; Middle Aged; Nifedipine; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Verapamil | 2001 |
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Blood Glucose; Cholesterol; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hemodynamics; Humans; Hypertension; Indoles; Insulin; Insulin Secretion; Male; Middle Aged; Nifedipine; Verapamil | 2002 |
4 other study(ies) available for nifedipine and trandolapril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |